Company / Current Liabilities per Share
Aligos Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.27
FY2025
5-year range
$0.27 / $7.24
FY2021-FY2025
Trend
-96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.56 to $0.27 over the past 2 years.
Based on SEC 10-K filings.
0.27 in FY2025 with a 5-year CAGR of -49.0%.
Improved from $0.56 to $0.27 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.0%
- 5-Year CAGR
- -49.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 96.3% year-over-year.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -96.3% |
| FY2024 | $7.24 | +1199.3% |
| FY2023 | $0.56 | -28.2% |
| FY2022 | $0.78 | -24.1% |
| FY2021 | $1.02 | -86.7% |
| FY2020 | $7.71 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026